Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000438778

Medchemexpress LLC nor-NOHA monoacetate | 2250019-93-1 | 99.9% | 236.23 | 100 MG
SDP

Catalog No. 5000438778
Encompass_Preferred

nor-NOHA monoacetate is a selective and reversible arginase inhibitor. It induces apoptosis in ARG2-expressing cells under hypoxia and exhibits anti-leukemic activity. It can be utilized in studies concerning endothelial dysfunction, immunosuppression, and metabolism.

  • Selective and reversible arginase inhibitor
  • Induces apoptosis in ARG2-expressing cells under hypoxia
  • Exhibits anti-leukemic activity
  • Can be used in studies of endothelial dysfunction, immunosuppression, and metabolism
  • Induces apoptosis in a dose-dependent manner in K562 cells under hypoxia
  • Attenuates hypoxia-mediated resistance towards imatinib in K562 or KCL22 cells
  • Induces a significant reduction of infarct size in male Sprague-Dawley rats
  • Increases plasma citrulline and nitrite levels and decreases ornithine plasma levels in male Sprague-Dawley rats

Catalog No. 50-004-38778 Supplier Medchemexpress LLC Supplier No. HY112885B100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

nor-NOHA monoacetate is a selective and reversible arginase inhibitor. It induces apoptosis in ARG2-expressing cells under hypoxia and exhibits anti-leukemic activity. It can be utilized in studies concerning endothelial dysfunction, immunosuppression, and metabolism.

  • Selective and reversible arginase inhibitor
  • Induces apoptosis in ARG2-expressing cells under hypoxia
  • Exhibits anti-leukemic activity
  • Can be used in studies of endothelial dysfunction, immunosuppression, and metabolism
  • Induces apoptosis in a dose-dependent manner in K562 cells under hypoxia
  • Attenuates hypoxia-mediated resistance towards imatinib in K562 or KCL22 cells
  • Induces a significant reduction of infarct size in male Sprague-Dawley rats
  • Increases plasma citrulline and nitrite levels and decreases ornithine plasma levels in male Sprague-Dawley rats

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.